Predicted LncRNA

DataTables

LncRNA Compound Cancer P-value Effect
ENSG00000241155.1 ABT-263 (navitoclax) Bladder urothelial carcinoma 0.026796821 Resistant
ENSG00000241155.1 ABT-263 (navitoclax) Skin cutaneous melanoma 0.016604194 Resistant